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cell transplantation has traditionally been to reconsti-
tute blood cell lineages that had formed abnormally
because of genetic mutations, or that had been eradi-
cated to treat a disease such as leukemia. However, in
recent years, compelling data has suggested that stem
cells from the bone marrow might have far greater
potential, and might be able to repair damaged or dis-
eased tissues outside of the blood-forming compart-
ment. Much attention has been paid to the concept
of ‘‘stem cell plasticity,’’ and the hope that stem cells
could be used to repair damaged tissues has generated
immense excitement in many fields.
Several types of adult human stem cells have been
identified and studied in tissue repair applications.
Most popular are hematopoietic stem cells, which
can reconstitute the entire blood system, and also
mesenchymal stem cells, which have the potential to
form bone, cartilage, muscle, and fat. Our group stud-
ies tissue repair by both hematopoietic and mesenchy-
mal stem cells, isolated from bone marrow, cord blood,
and adipose tissue, in immune-deficient mouse models
of injury and disease.
Immune-deficient mouse models of tissue damage
provide a system in which human stem cell migration
to sites of damage and subsequent contribution to
repair can be carefully evaluated. Popular strains
have been discussed in a review paper [1], and newer
strains such as NOD/SCID/IL2RG2/2 (deficient in
the common gamma chain of IL-2 and other lymphoid
cytokines) are available. The beta-glucuronidase
(GUSB)-deficient NOD/SCID/MPSVII mouse [2]
allows the sensitive detection of individual unmarked
donor cells (mouse, human, canine, etc.) in engrafted
tissues by normal levels of the enzyme, without
reliance on the continued expression of human cell
surface markers or in situ hybridization. A simple sub-
strate reaction is used on tissue slides. This mouse is
highly useful for tissue repair studies, because the
transplanted cells can be found in the tissues, by flowcytometry or on slides, without the use of antibody
technology. This reduces background and errors in in-
terpretation. Another benefit is that the transplanted
cells do not need to be first manipulated to tag them
with a vector, membrane dye, or other particle that
would identify them later; they are detected based
only on their innate expression of the enzyme beta-
glucuronidase, absent in the mice.
Immune-deficient mice provide easily accessible in
vivo models for studying human stem cell migration,
engraftment, and contribution to the repair of tissue
damage. They can be used to test tissue repair strate-
gies, because most of the cytokines, chemokines, and
inflammatory modulators involved with stem cell
recruitment and activation are conserved from mouse
to humans. Hematopoietic stem cells from adult sour-
ces such as bone marrow (BM), mobilized peripheral
blood (MPB), adipose tissue, and umbilical cord blood
(UCB) have been shown, in our laboratory and others,
to promote tissue repair in immune-deficient mouse
models. Different populations of stem cells have been
described to contribute to the regeneration of muscle
[3,4], liver [5-8], heart [9-12], and to regenerate vascu-
lature [13-15], although the mechanisms by which they
accomplish this are still not well understood. Stem cells
are known, however, to secrete a variety of cytokines
and growth factors that have both paracrine and
autocrine activities. One theory of tissue repair and
regeneration by adult stem cells is that the mechanism
of action is based upon the innate functions of the stem
cells: the injected stem cells home to the injured area,
in particular to hypoxic and/or inflamed areas, and re-
lease trophic factors that hasten endogenous repair.
These secreted bioactive factors suppress the local im-
mune system, enhance angiogenesis, inhibit fibrosis
and apoptosis, and stimulate recruitment, retention,
mitosis, and differentiation of tissue-residing stem
cells. These effects, which are referred to as trophic ef-
fects, are distinct from the direct differentiation of
stem cells into the tissue to be regenerated.151
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adipose and BM-derived MSC lodge in multiple tis-
sues following various routes of administration into
sublethally irradiated immune-deficient mice [16].
Yet in models of acute local injury, MSC appear to
preferentially home to, or accumulate in, the damaged
tissue [11]. Our group has studied the trafficking of
human BM and UCB-derived aldehyde dehydroge-
nase (ALDH)1, CD341, and more highly purified
subpopulations, and of BM and adipose tissue-derived
mesenchymal stem cells to damaged heart, liver,
muscle, pancreas, and to the ischemic limbs of im-
mune-deficient mice. Cell trafficking and functional
outcomes from intravenous injection of the stem cell
populations versus nonstem cell controls (ie, ALDH
hi versus ALDH lo sorted populations) were assessed.
Trafficking was determined using fluorescent nano-
particle labeling and in vivo dynamic imaging. End-
points were determined by FACS analysis and by
tissue staining using the NOD/SCID/MPSVII mouse,
where unmarked donor-derived cells can be easily
identified using a simple enzymatic substrate reaction.
Within each study, mice were assessed in groups large
enough to achieve statistical significance. The groups
that had received the stem cell populations demon-
strated improved regional blood flow and tissue func-
tion, compared with the nonstem cell-injected control
groups, at various time points after transplantation.
However, very few donor marker-positive cells were
found incorporated into vascular structures or in the
repaired tissue. Tissue staining in the damaged regions
revealed that the transplanted human cells had under-
gone very few cell divisions after homing to the area of
hypoxia or inflammation.
The paucity of human cells remaining in the tissue
after repair suggest that the tissue improvements that
were observed were not the result of generation of
transplanted cell-derived endothelial cells, muscle,
liver, or beta cells, but suggest that cytokines secreted
from transplanted cells potentiated angiogenic activity
and tissue repair from endogenous murine cells.
Although the combinations of factors involved are still
being established, our data indicate that adult human
stem cells do not become a significant part of the dam-
aged tissue, but rapidly home to and persist only tem-
porarily at a site of hypoxia or inflammation to exert
significant trophic effects on tissue repair.
It is important to note that, with over 400 mice
now analyzed in these tissue repair experiments, no
adult human stem cell-derived tumors have ever been
observed. The mouse strains used have no capacity
to reject the human cells, and thus were a valid model
for testing the tumorigenesis abilities of adult stem
cells (Dao, Bauer et al, submitted). Both MSC and
HSC have been tested extensively without a single
occurrence of a stem cell-derived tumor. However,
the immune-compromised mice were susceptible tohuman leukemias, caused by preexisting leukemic or
preleukemic cells in the transplanted cell populations.
The spontaneous emergence of the leukemias would
likely not have occurred in the presence of functioning
NK cells in the mice.
In contrast to the hematopoietic and mesenchymal
cells that have been isolated using standard techniques,
novel populations of cells have been identified by in-
vestigators who ‘‘think outside the box,’’ as exemplified
by exciting work done in the laboratory headed by
Mariusz Ratajczak. In addition to cytokines, Ratajczak
et al. [17] have shown that microvesicles (MV) can play
a role in cell-cell interactions. MV are tiny, between
100 nm to 1 mm, are shed by cells, and can be vehicles
for transferring mRNA and can activate various signal-
ing pathways. Ratajczak’s group found that micropar-
ticles (MP), MV shed from platelets, can be used to
heighten the rapidity of HSC engraftment as well as
enhance the level of engraftment in lethally irradiated
mice [18]. Furthermore, when MV from human em-
bryonic stem cells were added to HSCs, they increased
the pluripotency of the cells as well as upregulating ex-
pression of Oct-4, Rex-1, and Nanog, cellular markers
of pluripotency [19].
Mitochondria have also been shown to play a role
in cellular repair. It has been shown that MSC, as
well as other cell types, are able to transfer their mito-
chondria to other cells to rescue the cells from death
[20]. In this study, MSC were added to cells treated
with ethidium bromide and were able to restore the
cell’s aerobic respiration as well as their ability to ex-
pand. The restoration of cellular functions was attrib-
uted to active mitochondrial transfer. Coculture with
mitochondria alone did not result in restored function,
nor was there nuclear DNA present, indicating that the
effects were not because of cell fusion.
Adult stem cells cannot create an entire tissue, as
can embryonic cells. However, under the right condi-
tions, adult stem cells can act as the ‘‘paramedics of the
body,’’ rushing to areas of hypoxia and rapidly causing
revascularization and releasing trophic factors to aide
in tissue repair, early after tissue injury. In a seminal
study by Evan Snyder’s group, using a primate Parkin-
sonian model, human Neural Stem Cells (hNSC) were
injected unilaterally and were found to traverse to the
other, damaged side of the brain. The stem cells were
found to both elicit endogenous repair in the damaged
host neurons as well as to differentiate into mature
neurons [20]. The active travel of the hNSC is further
support for the active rescue nature of adult stem and
progenitor cells.
In addition to the cell types described above,
human embryonic stem cells are being explored, with
the hope that they can repair all tissues and will more
robustly ‘‘become’’ the tissue, as has been proven for
murine embryonic stem cells. Because these cells
were first reported in 1998, the field is new, but
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models are needed, and more models of disease and tis-
sue injury in animals that are immune deficient, so can
accept the human cell graft, will need to be developed
to further strengthen these efforts. The combination
of embryonic and adult stem cell treatments could
also prove beneficial for tissue repair, perhaps provid-
ing long- and short-term engraftment and support sys-
tems for the injured tissues. More experiments need to
be done to further investigate the many prospects of
this burgeoning field, to bring the most effective
stem cell-based therapies to our many community
members who urgently need them.
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